7XXM
Orf1-glycine-4-aminobutylthricin complex
7XXM の概要
エントリーDOI | 10.2210/pdb7xxm/pdb |
分子名称 | N-formimidoyl fortimicin A synthase, FLAVIN-ADENINE DINUCLEOTIDE, GLYCINE, ... (5 entities in total) |
機能のキーワード | 4-aminobutylthricin oxidoreductase, oxidoreductase |
由来する生物種 | Streptomyces luteocolor |
タンパク質・核酸の鎖数 | 8 |
化学式量合計 | 450983.91 |
構造登録者 | |
主引用文献 | Wang, Y.L.,Chang, C.Y.,Hsu, N.S.,Lo, I.W.,Lin, K.H.,Chen, C.L.,Chang, C.F.,Wang, Z.C.,Ogasawara, Y.,Dairi, T.,Maruyama, C.,Hamano, Y.,Li, T.L. N-Formimidoylation/-iminoacetylation modification in aminoglycosides requires FAD-dependent and ligand-protein NOS bridge dual chemistry. Nat Commun, 14:2528-2528, 2023 Cited by PubMed Abstract: Oxidized cysteine residues are highly reactive and can form functional covalent conjugates, of which the allosteric redox switch formed by the lysine-cysteine NOS bridge is an example. Here, we report a noncanonical FAD-dependent enzyme Orf1 that adds a glycine-derived N-formimidoyl group to glycinothricin to form the antibiotic BD-12. X-ray crystallography was used to investigate this complex enzymatic process, which showed Orf1 has two substrate-binding sites that sit 13.5 Å apart unlike canonical FAD-dependent oxidoreductases. One site could accommodate glycine and the other glycinothricin or glycylthricin. Moreover, an intermediate-enzyme adduct with a NOS-covalent linkage was observed in the later site, where it acts as a two-scissile-bond linkage facilitating nucleophilic addition and cofactor-free decarboxylation. The chain length of nucleophilic acceptors vies with bond cleavage sites at either N-O or O-S accounting for N-formimidoylation or N-iminoacetylation. The resultant product is no longer sensitive to aminoglycoside-modifying enzymes, a strategy that antibiotic-producing species employ to counter drug resistance in competing species. PubMed: 37137912DOI: 10.1038/s41467-023-38218-w 主引用文献が同じPDBエントリー |
実験手法 | X-RAY DIFFRACTION (2.119 Å) |
構造検証レポート
検証レポート(詳細版)をダウンロード